Table 1.
Comparison analysis between group A and group B on baseline clinical and biochemical parameters.
| Group A (n=80) | Group B (n=65) | p | |
|---|---|---|---|
| Age (year) | 11.6 ± 2.3 | 11.8 ± 2.7 | 0.738 |
| Sex (male/female) | 36/44 | 29/36 | 0.963 |
| Pubertal/pre-pubertal | 55/25 | 43/22 | 0.740 |
| Height SDS | 0.36 +/- 1.066 | 0.38 +/- 1.14 | 0.913 |
| BMI (kg/m2) | 29.75 +/- 4.37 | 29.79 +/- 4.76 | 0.962 |
| BMI SDS | 3.00 +/- 0.57 | 3.12 +/- 1.07 | 0.455 |
| WC (cm) | 87.56 +/- 9.41 | 89.78 +/- 12.01 | 0.271 |
| WHtR | 0.89 +/- 0.07 | 0.89 +/- 0.08 | 0.924 |
| SBP (mmHg) | 114.80 +/- 11.84 | 116.26 +/- 12.43 | 0.510 |
| DBP (mmHg) | 71.31 +/- 10.66 | 71.16 +/- 10.94 | 0.940 |
| Fasting glucose (mg/dl) | 94.29 +/- 7.31 | 94.69 +/- 10.87 | 0.798 |
| Fasting insulin (mIU/L) | 23.49 +/- 16.78 | 20.85 +/- 10.60 | 0.250 |
| HbA1c | 5.44 +/- 0.38 | 5.41 +/- 0.41 | 0.061 |
| 2h-glucose (mg/dl) | 123.76 +/- 20.64 | 122.32 +/- 29.46 | 0.742 |
| 2h-insulin (mIU/L) | 127.07 +/- 100.22 | 104.68 +/- 60.95 | 0.100 |
| HOMA-IR | 5.52 +/- 4.02 | 4.91 +/- 2.63 | 0.407 |
| Total cholesterol (mg/dl) | 168.11 +/- 26.54 | 174.51 +/- 29.52 | 0.177 |
| HDL cholesterol (mg/dl) | 47.77 +/- 10.17 | 51.14 +/- 12.49 | 0.083 |
| LDL cholesterol (mg/dl) | 96.36 +/- 22.71 | 100.12 +/- 29.77 | 0.347 |
| Triglycerides (mg/dl) | 97.09 +/- 48.81 | 90.52 +/- 37.73 | 0.363 |
| TSH (μUI/ml) | 3.08 +/- 1.35 | 2.68 +/- 1.42 | 0.087 |
| FT4 (ng/dl) | 1.26 +/- 0.15 | 1.22 +/- 0.14 | 0.144 |
| ALT (U/L) | 24.59 +/- 28.58 | 23.34 +/- 15.70 | 0.739 |
| AST (U/L) | 26.56 +/- 31.15 | 21.00 +/- 6.89 | 0.124 |
| GGT (U/L) | 15.16 +/- 7.02 | 14.75 +/- 8.23 | 0.795 |
| Uric acid (mg/dl) | 4.92 +/- 1.25 | 5.05 +/- 1.16 | 0.516 |
| CRP (mg/dl) | 3.25 +/- 7.54 | 2.89 +/- 3.16 | 0.701 |
Subjects evaluated before the Covid-19 pandemic (Group A); subjects evaluated in the period straddling the Covid-19 pandemic (Group B), Body mass index (BMI), standard deviation score (SDS), waist circumference (WC), WC-to-height ratio (WHtR), systolic blood pressure (SBP), diastolic blood pressure (DBP), alanine aminotransferase (ALT), aspartate aminotransferase (AST), Gamma-Glutamyl Transferase (GGT), glycated haemoglobin (HbA1c), 120-minutes OGTT glucose levels (2h- glucose), 120-minutes OGTT insulin levels (2h-insulin), model assessment of insulin resistance (HOMA-IR), free thyroxine (FT4), thyroid stimulating hormone (TSH), c-reactive protein (CRP).